Andrea Diociaiuti

Dr. Andrea Diociaiuti

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MHMay El Hachem
May El Hachem
GZGiovanna Zambruno
Giovanna Zambruno
EBEva Bourdon-Lanoy
Eva Bourdon-Lanoy
ACAnnalisa Ciasulli
Annalisa Ciasulli
CBChristiane Buisson
Christiane Buisson
CBChristine Bodemer
Christine Bodemer
Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by fragility and blistering of skin and mucous membranes. Clinical features combined with immunofluorescence antigen mapping and/or electron microscopy examination of a skin biopsy allow to define the EB type and subtype. Molecular diagnosis is nowadays feasible in all EB subtypes and required for prenatal diagnosis. The extent of skin and mucosal lesions varies greatly depending on EB subtype and patient age. In the more severe EB subtypes lifelong generalized blistering, chronic ulcerations and scarring sequelae lead to multiorgan involvement, major morbidity and life-threatening complications. In the absence of a cure, patient management remains based on preventive measures, together with symptomatic treatment of cutaneous and extracutaneous manifestations and complications. The rarity and complexity of EB challenge its appropriate care. Thus, the aim of the present study has been to generate multicentre, multidisciplinary recommendations on global skin care addressed to physicians, nurses and other health professionals dealing with EB, both in centres of expertise and primary care setting.

2 July 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MHM. El Hachem
M. El Hachem
ADAndrea Diociaiuti
Andrea Diociaiuti
CCC. Concato
C. Concato
RCR. Carsetti
R. Carsetti
CCC. Carnevale
C. Carnevale
RAR. Alaggio
R. Alaggio

15 August 2019 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Carlo CaffarelliCarlo Caffarelli
Carlo Caffarelli
FPFrancesco Paravati
Francesco Paravati
MHMay El Hachem
May El Hachem
MDmarzia duse
marzia duse
MBMarcello Bergamini
Marcello Bergamini
FCFabio Cardinale
Fabio Cardinale
The aim of this guidance is to provide recommendations to clinicians and other interested parties on chronic urticaria in children. The Italian Society for Pediatrics (SIP), the Italian Society for Allergy and Immunology (SIAIP), the Italian Society for Pediatric dermatology (SIDerP) convened a multidisciplinary panel that prepared clinical guidelines for diagnosis and management of chronic urticaria in childhood. Key questions on epidemiology, natural history, diagnosis, and management were developed. The literature was systematically searched and evaluated, recommendations were rated and algorithms for diagnosis and treatment were developed. The recommendations focus on identification of diseases and comorbidities, strategies to recognize triggering factors, improvement of treatment by individualized care.

28 March 2019 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
VKV.A. Kinsler
V.A. Kinsler
OBO. Boccara
O. Boccara
SFS. Fraitag
S. Fraitag
ATAntonio Torrelo
Antonio Torrelo
PVP. Vabres
P. Vabres
ADAndrea Diociaiuti
Andrea Diociaiuti

2 March 2016 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
EGElena Galli
Elena Galli
INIria Neri
Iria Neri
Giampaolo RicciGiampaolo Ricci
Giampaolo Ricci
EBErmanno Baldo
Ermanno Baldo
MBMaurizio Barone
Maurizio Barone
LELawrence F. Eichenfield
Lawrence F. Eichenfield
The Italian Consensus Conference on clinical management of atopic dermatitis in children reflects the best and most recent scientific evidence, with the aim to provide specialists with a useful tool for managing this common, but complex clinical condition. Thanks to the contribution of experts in the field and members of the Italian Society of Pediatric Allergology and Immunology (SIAIP) and the Italian Society of Pediatric Dermatology (SIDerP), this Consensus statement integrates the basic principles of the most recent guidelines for the management of atopic dermatitis to facilitate a practical approach to the disease. The therapeutical approach should be adapted to the clinical severity and requires a tailored strategy to ensure good compliance by children and their parents. In this Consensus, levels and models of intervention are also enriched by the Italian experience to facilitate a practical approach to the disease.

28 February 2017 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MHMay El Hachem
May El Hachem
FGFrancesco Gesualdo
Francesco Gesualdo
Giampaolo RicciGiampaolo Ricci
Giampaolo Ricci
ADAndrea Diociaiuti
Andrea Diociaiuti
LGLoredana Giraldi
Loredana Giraldi
INIria Neri
Iria Neri
Families of children affected with atopic dermatitis (AD) often report fear and anxiety regarding treatment with topical corticosteroids (TCS), which may lead to reduced compliance. The objective of our study was to measure, through a standardized questionnaire, fear of TCS in families of pediatric patients with AD and to identify items associated with fear. Families of pediatric patients with AD were enrolled in 9 Italian centers of pediatric dermatology. Enrolled parents were invited to fill in a questionnaire including questions on sociodemographic and clinical characteristics and 3 sets of questions on corticosteroid phobia (general fear, specific fears, behaviours regarding TCS). Determinants of the level of general fear were investigated through multivariable analysis. A total of 300 outpatients with AD were enrolled. Most parents (80%) had a high instruction level. Eighty-one percent reported to have a certain amount of fear of TCS. At the multivariable analysis, fear of TCS was associated with the following items: believing that TCS treatment advantages do not overweight disadvantages (P = 0.011); believing that TCS may be dangerous independently from the specific side effect (P < 0.001). Moreover, TCS fear was associated with fear of applying too much cream (P = 0.001). TCS phobia is widespread among Italian families of children with AD. Fear of TCS is associated with fear of applying too much cream, thus increasing the risk of poor compliance and treatment failure. Therapeutic education of families on the use of TCS should be implemented.